David Wayne Robinson serves as Global CCO at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, David Wayne Robinson has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 21, 2026 involved receiving (via award) 416,000 shares valued at $0.
David Wayne Robinson currently holds 416,000 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Global CCO.
Based on SEC Form 4 filings, David Wayne Robinson has been a net neutral trader of OCUL stock. They have purchased $0 and sold $0 worth of shares.
David Wayne Robinson's most recent insider trade was on Jan 21, 2026, when they sold 416,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |